{"id":"antiarrhythmic-drug-aad","safety":{"commonSideEffects":[{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Proarrhythmic effects"},{"rate":null,"effect":"Gastrointestinal disturbances"}]},"_chembl":{"chemblId":"CHEMBL1909414","moleculeType":"Small molecule","molecularWeight":"508.02"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiarrhythmic drugs suppress abnormal electrical impulses in the heart that cause irregular heartbeats. They work through various mechanisms including sodium channel blockade, beta-adrenergic antagonism, potassium channel blockade, or calcium channel inhibition, depending on the specific drug class. By slowing conduction velocity or prolonging refractory periods, they help restore coordinated electrical activity and normal sinus rhythm.","oneSentence":"Antiarrhythmic drugs work by modulating cardiac electrical activity to restore normal heart rhythm.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:17:09.661Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation"},{"name":"Ventricular arrhythmias"},{"name":"Supraventricular tachycardia"}]},"trialDetails":[{"nctId":"NCT06669299","phase":"NA","title":"Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-06-12","conditions":"Ventricular Tachycardia (VT)","enrollment":51},{"nctId":"NCT05034432","phase":"PHASE4","title":"The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2022-05-27","conditions":"Arrythmia, Cardiomyopathies","enrollment":100},{"nctId":"NCT05524077","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2020-07-08","conditions":"Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated","enrollment":162},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT06096337","phase":"NA","title":"Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2023-12-28","conditions":"Persistent Atrial Fibrillation","enrollment":484},{"nctId":"NCT06735534","phase":"NA","title":"Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-06-03","conditions":"Persistent Atrial Fibrillation","enrollment":407},{"nctId":"NCT06783868","phase":"","title":"Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-10","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT01803438","phase":"PHASE4","title":"Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Medtronic Cardiac Ablation Solutions","startDate":"2014-06","conditions":"Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases","enrollment":220},{"nctId":"NCT02913014","phase":"NA","title":"Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy","status":"COMPLETED","sponsor":"Prisma Health-Midlands","startDate":"2017-06-28","conditions":"Atrial Fibrillation","enrollment":50},{"nctId":"NCT04160000","phase":"PHASE4","title":"Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure","status":"RECRUITING","sponsor":"Electrophysiology Research Foundation","startDate":"2020-07-26","conditions":"Atrial Fibrillation, Heart Failure, Diastolic Heart Failure","enrollment":360},{"nctId":"NCT04942834","phase":"NA","title":"Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2021-10-01","conditions":"Atrial Fibrillation, Persistent, Arrhythmias, Cardiac","enrollment":286},{"nctId":"NCT05185310","phase":"NA","title":"Strategies in Patients Undergoing Repeat AF Ablation","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2021-12-13","conditions":"Atrial Fibrillation","enrollment":8},{"nctId":"NCT04223310","phase":"NA","title":"Clinical Usefulness of Virtual Antiarrhythmic Drug Test in Patients With Recurred AF After Catheter Ablation(CUVIA-AF3)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2023-06-13","conditions":"Atrial Fibrillation","enrollment":300},{"nctId":"NCT04512911","phase":"EARLY_PHASE1","title":"Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-01","conditions":"Ventricular Tachycardia","enrollment":""},{"nctId":"NCT05364866","phase":"","title":"CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-05-01","conditions":"Cardiovascular Diseases","enrollment":200},{"nctId":"NCT05514860","phase":"NA","title":"The Impact of \"First-Line\" Rhythm Therapy on AF Progression","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2017-01","conditions":"Atrial Fibrillation","enrollment":303},{"nctId":"NCT02825979","phase":"NA","title":"Early Aggressive Invasive Intervention for Atrial Fibrillation","status":"UNKNOWN","sponsor":"Jason Andrade","startDate":"2017-01","conditions":"Atrial Fibrillation","enrollment":303},{"nctId":"NCT03228823","phase":"PHASE4","title":"Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)","status":"UNKNOWN","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2018-08-01","conditions":"Ventricular Premature Beats, Contractions, or Systoles, Cardiomyopathies","enrollment":5},{"nctId":"NCT02633774","phase":"NA","title":"Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-11","conditions":"Persistent Atrial Fibrillation","enrollment":200},{"nctId":"NCT01490814","phase":"NA","title":"FIRE AND ICE: Comparative Study of Two Ablation Procedures in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"Medtronic Atrial Fibrillation Solutions","startDate":"2011-12","conditions":"Symptomatic Paroxysmal Atrial Fibrillation (PAF)","enrollment":769},{"nctId":"NCT03607123","phase":"","title":"Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-07-04","conditions":"Sinus Node Dysfunction, Atrial Fibrillation","enrollment":200},{"nctId":"NCT01477983","phase":"PHASE4","title":"Kansai Plus Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2011-11","conditions":"Atrial Fibrillation","enrollment":2113},{"nctId":"NCT00231296","phase":"NA","title":"Safety and Efficacy of CryoCor™ Cryoablation for PAF","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2004-11","conditions":"Atrial Fibrillation","enrollment":174},{"nctId":"NCT02114528","phase":"PHASE4","title":"Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2014-10","conditions":"Ventricular Tachycardia, Ventricular Arrhythmia","enrollment":40},{"nctId":"NCT01709682","phase":"PHASE2","title":"A Comparison of the Drug Therapy Versus Re-Ablation","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2007-11","conditions":"Paroxysmal Atrial Fibrillation, Failed First Radiofrequency Ablation Procedure","enrollment":154},{"nctId":"NCT00477230","phase":"PHASE3","title":"Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs","status":"TERMINATED","sponsor":"CardioFocus","startDate":"2007-03","conditions":"Atrial Fibrillation","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Brand names; Tambocor, Pronon, Sotacor, Ancaron"],"phase":"marketed","status":"active","brandName":"Antiarrhythmic drug (AAD)","genericName":"Antiarrhythmic drug (AAD)","companyName":"Kyoto University, Graduate School of Medicine","companyId":"kyoto-university-graduate-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiarrhythmic drugs work by modulating cardiac electrical activity to restore normal heart rhythm. Used for Atrial fibrillation, Ventricular arrhythmias, Supraventricular tachycardia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}